Navigation Links
Immediate Treatment of Early MS Patients with Betaferon,Significantly Delayed Permanent Disability

-breaking results,” said Darlene Jody, M.D., President of Bayer HealthCare’s Specialized Therapeutics Global Business Unit. “In the past year, Betaferon® has received approval around the world for use in patients with the earliest signs of MS. We intend to submit this novel data for inclusion in our label. Regulatory approval would further differentiate Betaferon® from other products in the market place and strengthen our position.”

About BENEFIT
BENEFIT is a multi-center trial conducted at 98 sites in 20 countries and included patients presenting with a single clinical episode suggestive of MS. A total of 468 patients with a first clinical demyelinating event suggestive of MS and typical MRI findings were randomized to receive either 250 micrograms of interferon beta-1b (Betaferon®) every other day or placebo as a subcutaneous injection in a double blind fashion. The placebo-controlled treatment period lasted up to 24 months or up to the time when patients were diagnosed with clinically definite MS. All study participants were then invited to participate in a follow-up study with Betaferon® to prospectively assess the impact of such immediate versus delayed treatment with Betaferon® on the long-term course of the disease for a total observation time of five years.

Results from a prospectively planned analysis of patients three years after the first event suggestive of MS showed that immediate treatment with Betaferon® after the first event suggestive of MS reduced the risk for confirmed EDSS progression by 40 percent over three years compared to delayed treatment. At three years, patients who initiated Betaferon® treatment immediately were 41 percent less likely to progress to clinically definite MS versus patients who began treatment later. These results confirm the findings of the placebo-controlled BENEFIT study.

At the end of three years, 73 percent of patients were
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
2. OREXIGEN Therapeutics Announces Sustained-Release Formulation of Zonisamide Shows Improved Tolerability When Compared to Immediate Release Formulation
3. First of Its Kind Data Show: Immediate Treatment of Early MS Patients with Betaseron Significantly Delayed Permanent Disability
4. Point of Care Strep Tests Speed Treatment, Lower Costs
5. Rapid HIV Testing Increases Possibility of Treatment
6. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
7. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
10. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
11. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
Post Your Comments:
(Date:9/18/2014)... Pa. , Sept. 18, 2014  Iliad Neurosciences, ... approaches to diagnosing and treating Autism Spectrum Disorders (ASD) ... License Agreement with The Research Foundation for The State ... Iliad will provide a new biomarker to identify an ... susceptibility to ASD. This biomarker is expected to be ...
(Date:9/18/2014)... 2014 Pharma IQ, ... incredibly successful Serialisation Countdown calendar to cover the years ... pharmaserialisation.com shows the serialisation requirements around the ... coming into force. For companies dealing with ... "if", but "when" they will have to comply with ...
(Date:9/18/2014)... CHICAGO , Sept. 18, 2014  Zacks.com announces ... Every day the Zacks Equity Research analysts discuss the ... markets. Stocks recently featured in the blog include the Avanir ... Pharmaceuticals (Nasdaq: NPSP - Free Report ), Orexigen ... MDVN - Free Report ) and Gilead (Nasdaq: ...
Breaking Medicine Technology:Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 2Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 3Pharma IQ Displays Worldwide Serialisation Deadlines in their 2014 - 2018 Countdown Calendar 2The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 2The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 4The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 5The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 6
... ,, ORLANDO, Fla. , May 17 The ... RunE2E and hosted in a secure, private cloud enabled by Freudenberg ... Cryo-Cell International, Inc., a pioneering healthcare company specializing in stem cell ... , ...
... May 17 Xenon Pharmaceuticals Inc. is pleased to announce today ... President, Research and Development. , ... "We are delighted to welcome Tarek to the Xenon team," commented ... R&D executive whose experience in discovering products, a number of which are ...
Cached Medicine Technology:RunE2E and Freudenberg IT Create Customer Value Through Implementation of SAP® CRM in Hosted, Private Cloud 2RunE2E and Freudenberg IT Create Customer Value Through Implementation of SAP® CRM in Hosted, Private Cloud 3RunE2E and Freudenberg IT Create Customer Value Through Implementation of SAP® CRM in Hosted, Private Cloud 4Xenon Announces Appointment of EVP, Research & Development 2
(Date:9/18/2014)... Memorial Cardiac and Vascular Institute ... by performing the first ever, adult heart transplant in ... Organ Sharing) approval to launch the adult heart transplant ... programs in South Florida. , The skilled cardiac ... Medical Director of the Adult Heart Transplant and ...
(Date:9/18/2014)... to diverse communities may boost infants, social learning, according ... in the park or supermarket could help children be ... different from them, researchers found. "Research has ... interacting with and learning from people who are different ... psychology professor, said in a university news release. ...
(Date:9/18/2014)... Reinberg HealthDay Reporter , THURSDAY, Sept. ... outbreak in West Africa is starting to spread faster than ever, ... cases of the deadly viral infection were reported in just one ... than 5,300, with roughly half of those reported in the past ... deaths now tops 2,600. WHO has estimated that as many ...
(Date:9/18/2014)... It’s been just a few short weeks ... bunion splint to website visitors, but already the response has ... absolutely delighted. It is perfect and I find it sooo ... THANK YOU FOR LISTENING!!!" Another user compared the original ... used to slip to the end of my toe. Now ...
(Date:9/18/2014)... 18, 2014 It is that time of ... and wellness. Once again, Evensong Spa at ... offering three services at a special $50 rate Oct. 20 ... Marcus Hotels & Resorts , is the only Wisconsin ... Americans to embrace health and wellness by experiencing affordable spa ...
Breaking Medicine News(10 mins):Health News:Memorial Cardiac & Vascular Institute Performs First Adult Heart Transplant in Broward County 2Health News:Memorial Cardiac & Vascular Institute Performs First Adult Heart Transplant in Broward County 3Health News:Memorial Cardiac & Vascular Institute Performs First Adult Heart Transplant in Broward County 4Health News:Study: Exposure to Diversity Might Boost Baby's Social Skills 2Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 2Health News:New Ebola Cases Top 700 in Just One Week, Officials Report 3Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:Evensong Spa Celebrates Spa Week with $50 Services 2Health News:Evensong Spa Celebrates Spa Week with $50 Services 3
... By Jenifer Goodwin HealthDay Reporter , ... genetic variants implicated in ADHD (attention-deficit/hyperactivity disorder) overlap with ... in autism, a new study finds. The ... ADHD, autism and other neuropsychiatric disorders sometimes have symptoms ...
... teenagers prefer social media over the telephone, you may want ... involved in research studies. When 188 ninth-11th graders in ... be contacted about their participation in a Georgia Health Sciences ... contact via cell and/or land line with a recorded message ...
... WEDNESDAY, Aug. 10 (HealthDay News) -- The breast cancer drug ... especially those with a history of heart disease and/or diabetes, ... of 45 women, ages 70 to 92, who were treated ... percent) of them developed heart problems caused by the drug. ...
... Aug. 10 (HealthDay News) -- Eating red meat -- especially ... of type 2 diabetes, a new study warns. It ... by replacing red meat with healthier proteins, such as nuts, ... Public Health researchers looked at 20 years of data from ...
... have had so far with the much-heralded field of nanotechnology ... of Chemical & Engineering News (C&EN), the American ... science of ultra-small particles so tiny that 50,000 could ... come when sunbathers, golfers, bikers and others slather on sunscreen ...
... DURHAM, N.H. A University of New Hampshire researcher ... pro-eugenic beliefs manipulated his research findings so he could ... mentally and morally "unfit" people. Benjamin Harris, professor ... has found that Yale psychologist Arnold Gesell manipulated the ...
Cached Medicine News:Health News:ADHD, Autism May Sometimes Share Gene Mutations 2Health News:ADHD, Autism May Sometimes Share Gene Mutations 3Health News:Telephone trumps social media when communicating with teens about research 2Health News:Breast Cancer Drug Raises Risk of Heart Problems in Older Women: Study 2Health News:Daily Hot Dog May Feed Diabetes Risk: Study 2Health News:UNH researcher discovers research manipulated to support pro-eugenic beliefs 2Health News:UNH researcher discovers research manipulated to support pro-eugenic beliefs 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: